naproxen has been researched along with warfarin in 54 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | naproxen (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (12.96) | 18.7374 |
| 1990's | 3 (5.56) | 18.2507 |
| 2000's | 24 (44.44) | 29.6817 |
| 2010's | 19 (35.19) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Andersson, K; Borg, P; Frostell-Karlsson, A; Hämäläinen, M; Karlsson, R; Remaeus, A; Roos, H | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Faller, B; Wohnsland, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Caron, G; Ermondi, G | 1 |
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Carrupt, PA; Martel, S; Ottaviani, G | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Romankiewicz, JA | 1 |
| Jain, A; Levy, G; McMahon, FG; Slattery, JT | 2 |
| Levy, G; Yacobi, A | 1 |
| Boost, G | 1 |
| Smith, RE; Theisen, AL | 1 |
| Felder, M | 1 |
| Bopp, BA; Kukulka, MJ; Machinist, JM | 1 |
| Gonzalez, FJ; Korzekwa, KR; Marra, C; Tracy, TS; Wrighton, SA | 1 |
| Chen, X; Luo, Q; Ni, J; Wang, H; Zhang, Q; Zou, H | 1 |
| Dockal, M; Il'ichev, YV; Perry, JL; Rüker, F; Simon, JD | 1 |
| Brouwers, JR; de Jong-van den Berg, LT; de Vries-Bots, AM; Piersma-Wichers, M; Plat, AW; Slomp, J; van Dijk, AA; van Dijk, KN | 1 |
| Andersen, A; Børmer, OP; Kongsgaard, UE; Nordbø, A; Olsen, H | 1 |
| Horie, T; Ji, B; Masubuchi, Y | 1 |
| Fielding, L; Fletcher, D; Rutherford, S | 1 |
| Benkestock, K; Edlund, PO; Roeraade, J | 1 |
| Oliveira, D; Tran, CD | 1 |
| Balchen, M; Gjelstad, A; Pedersen-Bjergaard, S; Rasmussen, KE | 1 |
| Jung, M; Mathias, U | 1 |
| Andersen, A; Kongsgaard, UE; Olsen, H; Reine, PA; Thøgersen, AK | 1 |
| Kuroda, Y; Saito, M; Sakai, H; Yamaoka, T | 1 |
| Choudhary, S; Kishore, N; Thoppil, AA | 1 |
| Hamaguchi, T; Inagaki, Y; Inoue, S; Iwakawa, S; Okada, M; Tatsumi, A | 1 |
| Hamaguchi, T; Inoue, S; Iwakawa, S; Tatsumi, A | 1 |
| Connell, CV; Danielson, ND; Dotlich, EM; Gibler, JN; Grossman, S; Mansour, FR; Norman, BE; Wei, W; Zhang, Y; Zhou, L | 1 |
| Bencsik, T; Boda, G; Fliszár-Nyúl, E; Kunsági-Máté, S; Lemli, B; Mohos, V; Poór, M | 1 |
| Escher, BI; Fischer, FC; Henneberger, L; Mühlenbrink, M | 1 |
| Khaibrakhmanova, D; Nikiforova, A; Sedov, I | 1 |
1 review(s) available for naproxen and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for naproxen and warfarin
| Article | Year |
|---|---|
[Clinical-pharmacological and pharmacokinetic studies with naproxen].
Topics: Administration, Oral; Animals; Antacids; Aspirin; Biological Availability; Clinical Trials as Topic; Coumarins; Drug Interactions; Gastric Mucosa; Half-Life; Humans; Injections, Intravenous; Kinetics; Models, Biological; Naphthaleneacetic Acids; Naproxen; Protein Binding; Rats; Sulfonylurea Compounds; Warfarin | 1975 |
Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES.
Topics: Adult; Aged; Albumins; Digitoxin; Female; Humans; Hydroxyethyl Starch Derivatives; Infusions, Parenteral; Male; Middle Aged; Naproxen; Pharmaceutical Preparations; Plasma Substitutes; Protein Binding; Surgical Procedures, Operative; Warfarin | 2008 |
51 other study(ies) available for naproxen and warfarin
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.
Topics: Binding Sites; Biosensing Techniques; Digitoxin; Drug Stability; Humans; Molecular Weight; Naproxen; Orosomucoid; Pharmaceutical Preparations; Protein Binding; Quinine; Rifampin; Ritonavir; Serum Albumin; Solvents; Warfarin | 2000 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of antacids on gastrointestinal absorption of drugs.
Topics: Animals; Antacids; Aspirin; Chlordiazepoxide; Chlorpromazine; Dicumarol; Digitoxin; Digoxin; Ephedrine; Guinea Pigs; Humans; Intestinal Absorption; Iron; Isoniazid; Levodopa; Naproxen; Pentobarbital; Pharmaceutical Preparations; Quinidine; Quinine; Rats; Sulfadiazine; Tetracyclines; Warfarin | 1976 |
Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
Topics: Adult; Blood Coagulation; Blood Proteins; Drug Interactions; Humans; Kinetics; Male; Naproxen; Protein Binding; Warfarin | 1979 |
Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
Topics: Adult; Aged; Blood Coagulation; Blood Proteins; Drug Interactions; Female; Humans; Male; Middle Aged; Naproxen; Protein Binding; Time Factors; Warfarin | 1979 |
Effect of naproxen on protein binding of warfarin in human serum.
Topics: Anti-Inflammatory Agents; Female; Humans; In Vitro Techniques; Naphthaleneacetic Acids; Naproxen; Protein Binding; Warfarin | 1976 |
Rheumatoid arthritis and hypercoagulable state.
Topics: Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Gold; Heparin; Humans; Middle Aged; Naproxen; Prednisone; Thrombophlebitis; Warfarin | 1990 |
[Non-steroidal antirheumatics: side-effects and interactions].
Topics: Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Drug Interactions; Gastrointestinal Diseases; Humans; Indomethacin; Naproxen; ortho-Aminobenzoates; Phenylbutazone; Prostaglandins; Rheumatic Diseases; Salicylates; Stomach Ulcer | 1982 |
In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite.
Topics: Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Anticoagulants; Blood Proteins; Chromatography, High Pressure Liquid; Drug Interactions; Female; Hematocrit; Humans; Hydroxylation; Hydroxyurea; Ibuprofen; In Vitro Techniques; Isotope Labeling; Lipoxygenase Inhibitors; Male; Naproxen; Prednisolone; Protein Binding; Salicylates; Stereoisomerism; Terfenadine; Theophylline; Warfarin | 1995 |
Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Dealkylation; Humans; In Vitro Techniques; Microsomes, Liver; Naproxen; Piroxicam; Sulfaphenazole; Tolbutamide; Transfection; Vaccinia virus; Warfarin | 1997 |
Synthesis and characteristics of the human serum albumin-triazine chiral stationary phase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atropine; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fenoprofen; Glutamic Acid; Humans; Ibuprofen; Naproxen; Protein Binding; Serum Albumin; Silicon Dioxide; Spectrophotometry, Ultraviolet; Stereoisomerism; Triazines; Tryptophan; Warfarin | 2000 |
Interaction of ochratoxin A with human serum albumin. Binding sites localized by competitive interactions with the native protein and its recombinant fragments.
Topics: Anions; Binding, Competitive; Fluorescence Polarization; Humans; Ligands; Models, Molecular; Molecular Structure; Naproxen; Ochratoxins; Peptide Fragments; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Serum Albumin; Warfarin | 2002 |
Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
Topics: Acenocoumarol; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Chi-Square Distribution; Cohort Studies; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; Drug Interactions; Female; Genotype; Humans; Ibuprofen; International Normalized Ratio; Male; Middle Aged; Naproxen; Retrospective Studies; Sex Factors; Time Factors; Warfarin | 2004 |
Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
Topics: Albumins; Digitoxin; Drug Industry; Humans; Naproxen; Pharmaceutical Preparations; Protein Binding; Serum Albumin; Warfarin | 2004 |
The relationship between oxidative metabolism and lipid peroxidation in rat liver microsomes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Guinea Pigs; Hypoglycemic Agents; Lipid Peroxidation; Luminescent Measurements; Male; Microsomes, Liver; Naproxen; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Tolbutamide | 2003 |
Determination of protein-ligand binding affinity by NMR: observations from serum albumin model systems.
Topics: Animals; Calorimetry; Cattle; Ibuprofen; Ligands; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Naproxen; Protein Binding; Proteins; Salicylates; Serum Albumin; Tryptophan; Warfarin | 2005 |
Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
Topics: Binding Sites; Digitoxin; Glyburide; Humans; Iopanoic Acid; Naproxen; Pharmaceutical Preparations; Protein Binding; Serum Albumin; Spectrometry, Mass, Electrospray Ionization; Warfarin | 2005 |
Fluorescence determination of enantiomeric composition of pharmaceuticals via use of ionic liquid that serves as both solvent and chiral selector.
Topics: Ions; Naproxen; Pharmaceutical Preparations; Propranolol; Quaternary Ammonium Compounds; Solvents; Spectrometry, Fluorescence; Stereoisomerism; Warfarin | 2006 |
Electrokinetic migration of acidic drugs across a supported liquid membrane.
Topics: Acids; Chromatography, Micellar Electrokinetic Capillary; Electrophoresis, Capillary; Flurbiprofen; Gemfibrozil; Heptanol; Hydrogen-Ion Concentration; Ketoprofen; Membranes, Artificial; Naproxen; Pharmaceutical Preparations; Probenecid; Reproducibility of Results; Warfarin | 2007 |
Determination of drug-serum protein interactions via fluorescence polarization measurements.
Topics: Blood Proteins; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chlorpromazine; Dipyridamole; Fluorescence Polarization; Fluorescent Dyes; gamma-Aminobutyric Acid; Humans; Naproxen; Orosomucoid; Phenylbutazone; Salicylic Acid; Serum Albumin; Warfarin | 2007 |
Rapid characterization of drug-drug interaction in plasma protein binding using a surface plasmon resonance biosensor.
Topics: Binding Sites; Biosensing Techniques; Blood Proteins; Drug Interactions; Humans; Naproxen; Phenylbutazone; Protein Binding; Surface Plasmon Resonance; Warfarin | 2008 |
Competitive binding of anticancer drugs 5-fluorouracil and cyclophosphamide with serum albumin: Calorimetric insights.
Topics: Animals; Antineoplastic Agents; Binding Sites; Binding, Competitive; Calorimetry; Carbenicillin; Cattle; Circular Dichroism; Cyclophosphamide; Fluorouracil; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Kinetics; Naproxen; Osmolar Concentration; Protein Binding; Quaternary Ammonium Compounds; Serum Albumin, Bovine; Stereoisomerism; Sucrose; Thermodynamics; Warfarin | 2016 |
Differences in Esterase Activity to Aspirin and p-Nitrophenyl Acetate among Human Serum Albumin Preparations.
Topics: Aspirin; Esterases; Humans; Hydrolysis; Indomethacin; Naproxen; Nitrophenols; Serum Albumin; Sulfhydryl Compounds; Warfarin | 2016 |
The Effect of Ethanol on the Hydrolysis of Ester-Type Drugs by Human Serum Albumin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antihypertensive Agents; Aspirin; Binding Sites; Drug Stability; Ethanol; Excipients; Fatty Acids, Nonesterified; Humans; Hydrolysis; Indomethacin; Kinetics; Ligands; Naproxen; Nitrophenols; Olmesartan Medoxomil; Preservatives, Pharmaceutical; Serum Albumin, Human; Warfarin | 2018 |
Liquid chromatography with alkylammonium formate ionic liquid mobile phases and fluorescence detection.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Daphnia; Formates; Ionic Liquids; L-Lactate Dehydrogenase; Naproxen; Pharmaceutical Preparations; Polyethylene Glycols; Riboflavin; Spectrometry, Fluorescence; Tryptophan; Warfarin | 2018 |
Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes.
Topics: Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Flavonoids; Fluorescence; Humans; Isoflavones; Naproxen; Resveratrol; Serum Albumin; Time Factors; Warfarin | 2018 |
C18-Coated Solid-Phase Microextraction Fibers for the Quantification of Partitioning of Organic Acids to Proteins, Lipids, and Cells.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Cattle; Cells, Cultured; Diclofenac; Genistein; HEK293 Cells; Humans; Ibuprofen; Kinetics; Liposomes; Naproxen; Phospholipids; Serum Albumin, Bovine; Solid Phase Microextraction; Torsemide; Warfarin | 2019 |
Evaluation of the binding properties of drugs to albumin from DSC thermograms.
Topics: Calorimetry, Differential Scanning; Ibuprofen; Isoniazid; Naproxen; Protein Binding; Serum Albumin, Bovine; Warfarin | 2020 |